Whoop & FDA 2026: A Surprising Win for Wearable Wellness

FDA Commissioner Marty Makary's 2026 guidance expands "General Wellness" exemptions, providing a regulatory win for WHOOP…

Whoop IPO and Glucose Monitoring Plans

Whoop CEO Will Ahmed confirms the company is considering an IPO within the next two years.…

Whoop vs FDA – Whoop bravely doubles down.

More: Whoop 5 Review | How this ended: Blood Pressure Watches: What Actually Works As initially…

WHOOP Fights Back Against FDA Warning – A Detailed Examination

Dispute with the FDA regarding whoop's Blood Pressure Insights